Lisdexamfetamine recalls: lots, NDC and companies
4 FDA recall records mention Lisdexamfetamine since December 11, 2024. Each covers specific lots from one company. Check yours below.
Check your Lisdexamfetamine bottle
Hazard and remedy text is quoted from the agency, unedited. The tag names the kind of risk with a word from that text. Every notice links to its official page.
Dissolution
SUN PHARMACEUTICAL INDUSTRIES INC: Lisdexamfetamine Dimesylate Capsules and 6 more
Hazard (FDA): Failed Dissolution Specifications: An out of specification results observed in dissolution test during analysis at 12-month long term stability station (25¿C, 60%RH) for Lisdexamfetamine dimesylate capsules.
FDAMedicines
Lannett Company Inc.: Lisdexamfetamine Dimesylate Capsules
Hazard (FDA): Labeling: Label Mix-up. A bottle labeled as Lisdexamphetamine Dimesylate Capsules 40mg, contained Lisdexamphetamine Dimesylate Capsules 30mg.
FDAMedicines
Dissolution
SUN PHARMACEUTICAL INDUSTRIES INC: Lisdexamfetamine Dimesylate Capsules
Hazard (FDA): Failed Dissolution Specifications: An out of specification results observed in dissolution test during analysis at 9 month long term stability station (25¿C, 60%RH).
FDAMedicines
Lannett Company Inc.: Lisdexamfetamine Dimesylate Capsules
Hazard (FDA): Failed Content Uniformity Specifications: Product failed to meet the action limits for stratified content uniformity.
FDAMedicines